Liraglutide became the first GLP-1 to be licensed for weight loss in this group in 2014, with the brand name Saxenda
Successful maintenance therapy is typically a combination of medication support, balanced nutrition, physical activity, and continuous monitoring
Retatrutide may become another option in the future, but for now, healthcare decisions should be based on medications that have already been approved for safety and effectiveness
Slots are filling up quickly, so act now and embark on your weight loss journey with us!
"Better health means greater productivity and fewer absences, including time off for medical care
He was curious about how microdosing a GLP-1 might help